Hologic Mammography Market Size to Surpass USD 8.82 Billion by 2035, Expanding at 10.26% CAGR Amid AI-Driven Innovations.
Advanced imaging technologies and rising breast cancer awareness propel the global Hologic mammography market from USD 3.32 billion in 2025 to USD 8.82 billion by 2035.
The Hologic mammography market surges forward, fueled by escalating breast cancer incidence, preventive screening initiatives, and breakthroughs in AI-enhanced 3D imaging that enable earlier detection. Key drivers include the shift from 2D to digital breast tomosynthesis (DBT), government-backed programs, and Hologic’s Genius AI Detection, which flags aggressive cancers with radiologist-level precision.
Hologic Mammography Market Key Insights
- North America commands the largest market share in 2025, driven by high screening adoption and advanced infrastructure.
- Asia Pacific emerges as the fastest-growing region at the highest CAGR through 2035, boosted by urbanization and public health reforms.
- Digital mammography dominates technology segments, while biopsy systems project the swiftest expansion due to minimally invasive precision.
- Hospitals lead end-user adoption, with diagnostic imaging centers accelerating growth via patient-centric workflows.
Market Revenue Overview
| Report Coverage | Details |
|---|---|
| Market Size in 2025 | USD 3.32 Billion |
| Market Size in 2026 | USD 3.66 Billion |
| Market Size by 2035 | USD 8.82 Billion |
| CAGR 2026-2035 | 10.26% |
| Largest Region | North America |
| Fastest Region | Asia Pacific |
AI’s Role in Hologic Mammography
Hologic’s Genius AI Detection revolutionizes screening by analyzing 3D mammography exams, correlating scores with tumor grades and lymph node status for superior identification of aggressive cancers. Clinical trials on over 7,500 exams show it flags one-third of prior false negatives and 90% of confirmed cases, matching expert radiologists while cutting reading times.
As a decision-support tool, AI enhances workflow in dense breasts, reduces recalls, and integrates seamlessly with systems like Genius 3D, positioning Hologic at the forefront of value-based care.
What Fuels Market Growth?
Rising global breast cancer rates demand early detection, amplified by awareness campaigns and incentives for 3D tomosynthesis over 2D methods. Technological leaps, including low-dose imaging and AI, improve accuracy by 20-65% for invasive cancers, while reimbursement expansions accelerate adoption.
What Opportunities and Trends Shape the Future?
Digital breast tomosynthesis slashes false positives and tissue overlap, gaining traction in dense breast screening with broader insurance coverage. Contrast-enhanced mammography (CEM) and AI hybrids emerge as trends, with Hologic partnering Bayer for adoption and launching Envision gantry in 2026 for faster scans.
Startup ecosystems thrive on AI software upgrades, while investor shifts—like Hologic’s Blackstone/TPG acquisitionsignal consolidation and R&D boosts.
Hologic Mammography Market Segmentation Highlights
Technology: Digital mammography leads with AI integration and patient-friendly features like SmartPaddle, reducing radiation by significant margins; DBT grows fastest for 3D accuracy in dense tissue.
Product Type: Mammography systems dominate via FDA-cleared 3D resolution; biopsy systems surge with add-on compatibility like Affirm Upright.
End User: Hospitals hold sway through comprehensive platforms; diagnostic centers expand rapidly with low-dose, high-comfort scans.
Hologic Mammography Market Regional Dynamics
North America dominates, propelled by incidence rates, advocacy, and seamless Hologic integration in U.S. networks. Asia Pacific accelerates via reforms in China and urban hubs, targeting late-stage reductions. Europe advances on EU strategies and Germany’s expanded screening, while Middle East & Africa builds infrastructure amid geriatric rises.
Hologic Mammography Market Top Companies
Key players include
- Hologic Inc.
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Fujifilm Holdings Corporation
- Canon Medical Systems,
- Carestream Health
- Planmed Oy.
Recent Breakthroughs
-
Hologic’s December 2025 data: Genius AI flags 32% more cancers in 7,500 exams.
-
Siemens’ January 2025: Mammomat B.brilliant delivers 5-second 3D scans.
Challenges and Cost Pressures
High upfront costs for DBT/AI systems hinder emerging market penetration, alongside radiologist shortages and training needs. Tariffs on components inflate prices, while regulatory hurdles and data security slow AI rollout in low-resource settings.
Real-World Impact: U.S. Screening Success
At Massachusetts General Hospital, Hologic’s AI retroactively identified 32% of missed cancers in 7,500 exams, enabling faster interventions and validating its role in high-volume workflows.
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7298
You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344
- Battery Swapping Market Size to Touch USD 24.74 Billion by 2035 - March 5, 2026
- Dental Air Polishing System Market Size to Reach USD 1603.54 Million by 2035 - March 4, 2026
- Cryoballoon Ablation System Market Size to Surpass USD 2.49 Billion by 2035, Propelled by 5.70% Growth in Minimally Invasive Cardiac Care - March 2, 2026
